| Sitagliptin | IC50 | 48000.0 [1] |
| Vildagliptin | IC50 | 9000.0 [1] |
| Vildagliptin | Ki | 810.0 [1], 1342.0 [2] |
| Alogliptin | IC50 | 100000.0 [1] |
| 1-Pentanone, 2-amino-3-methyl-1-(3-thiazolidinyl)-, (2S,3S)- | IC50 | 2170.0 [1] |
| Allo-Ile-Isoindoline | IC50 | 120.0 [1] |
| Linagliptin | IC50 | 40000.0 [1], 100000.0 [2] |
| N4-(4-Chlorobenzyl)-2,4-diaminobutanoylpiperidine | IC50 | 142000.0 [1] |
| Saxagliptin | IC50 | 240.0 [1], 244.0 [2] |
| Saxagliptin | Ki | 130.0 [1] |
| Talabostat | IC50 | 5.5 [1], 17.0 [2] |
| Talabostat | Ki | 1.5 [1] |
| (2S)-1-(2-((2-((5-Cyano-2-pyridyl)amino)ethyl)amino)acetyl)pyrrolidine-2-carbonitrile | IC50 | 4573.0 [1] |
| Chg-Pro-CN | IC50 | 27.0 [1] |
| 2-[3-[2-[2-Cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,3-dihydroisoindole | IC50 | 20000.0 [1], 100000.0 [2] |
| (2S)-1-[(2S)-2-Amino-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-4-oxobutanoyl]pyrrolidine-2-carbonitrile | IC50 | 14.0 [1], 16.0 [2] |
| (2S,3S)-2-Amino-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one;2,2,2-trifluoroacetic acid | IC50 | 87000.0 [1], 88000.0 [2] |
| CID 56658139 | IC50 | 12.0 [1], 14.0 [2] |
| (2S)-1-[2-[[(3Ar,6aS)-5-methoxy-1,2,3,3a,4,5,6,6a-octahydropentalen-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile | IC50 | 23.0 [1], 235.0 [2], 3570.0 [3] |
| 2-Amino-3-methyl-1-pyrrolidin-1-YL-butan-1-one | IC50 | 5200.0 [1] |
| Omarigliptin | IC50 | 67000.0 [1], 100000.0 [2] |
| Ala-boroPro | IC50 | 13.0 [1] |
| Ala-boroPro | Ki | 2.0 [1] |
| (R)-1-(2-Aminoacetyl)pyrrolidin-2-ylboronic acid | IC50 | 180.0 [1] |
| (R)-1-(2-Aminoacetyl)pyrrolidin-2-ylboronic acid | Ki | 3.1 [1] |
| N-(1-Napthalenecarbonyl)-Gly-boroPro | IC50 | 1200.0 [1], 3700.0 [2] |
| N-[4-[(1S)-1-Amino-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl]cyclohexyl]-2,4-difluorobenzenesulfonamide | IC50 | 993.0 [1] |
| Val-boroAla | IC50 | 670.0 [1] |
| Val-boroAla | Ki | 96.0 [1] |
| ((2S,4S)-4-(4-(4-Nitrophenyl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone | IC50 | 12.0 [1], 12.2 [2] |
| Ile-Isoindoline | IC50 | 1300.0 [1], 1320.0 [2] |
| (2S,3S)-3-Amino-2-[4-(4-fluorophenyl)phenyl]-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxobutanamide | IC50 | 100.0 [1], 100000.0 [2] |
| Sitagliptin Hydrochloride | IC50 | 48000.0 [1] |
| 3-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N-(2-phenylethyl)propanamide | IC50 | 2592.0 [1] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide;2,2,2-trifluoroacetic acid | IC50 | 100000.0 [1] |
| 3-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N-(3,4-dimethoxyphenyl)-3-methylbutanamide | IC50 | 20000.0 [1], 50000.0 [2] |
| (5-(2,4-Dichlorophenyl)-2-(2-methoxyphenyl)-7-methylimidazo[1,2-a]pyrimidin-6-yl)methanamine | Ki | 7800.0 [1], 10000.0 [2] |
| 3-[2-(2-Cyanopyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-N-(1-methyl-1-phenylethyl)butyramide | IC50 | 20000.0 [1], 100000.0 [2] |
| N-Benzyl-3-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]propanamide | IC50 | 10744.0 [1] |
| 3-[2-(2-Cyano-(S)-pyrrolidin-1-yl)-2-oxoethylamino]-N-phenylpropionamide | IC50 | 855.0 [1], 855.5 [2] |
| 3-[2-(2-Cyano-(S)-pyrrolidin-1-yl)-2-oxoethylamino]-N-(1-methyl-1-phenylethyl)propionamide | IC50 | 8338.0 [1] |
| (2S,3S)-2-Amino-1-pyrrolidin-1-yl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]butan-1-one | IC50 | 100000.0 [1] |
| (2S)-1-[(2S)-2-Amino-4-oxo-4-(1,2,3,4-tetrahydroisoquinolin-2-yl)butanoyl]pyrrolidine-2-carbonitrile | IC50 | 19.0 [1], 120.0 [2] |
| 4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,4-diazepan-2-one | IC50 | 42000.0 [1], 82000.0 [2] |
| (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine | IC50 | 100000.0 [1] |
| (3R)-3-Amino-4-(2-fluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one | IC50 | 75000.0 [1] |
| (2S,4S)-1-[(2S,3R)-2-Amino-3-methylpentanoyl]-4-azidopyrrolidine-2-carbonitrile | IC50 | 11.0 [1] |
| (S)-2,6-Diamino-1-(isoindolin-2-yl)hexan-1-one | IC50 | 200.0 [1] |
| (S)-Benzyl 5-amino-6-(isoindolin-2-yl)-6-oxohexylcarbamate | IC50 | 200.0 [1] |
| (2S,3S)-3-Amino-2-[4-(4-fluorophenyl)phenyl]-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxobutanamide;2,2,2-trifluoroacetic acid | IC50 | 100000.0 [1] |
| (2S,3S)-2-Amino-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one | IC50 | 88.0 [1], 88000.0 [2] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-5-yl)cyclohexyl]butanamide | IC50 | 53000.0 [1], 100000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-5-yl)cyclohexyl]butanamide | IC50 | 33000.0 [1], 95000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)cyclohexyl]butanamide | IC50 | 30000.0 [1], 100000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-2-[4-(4-fluorophenyl)cyclohexyl]-N,N-dimethyl-4-oxobutanamide | IC50 | 41000.0 [1], 100000.0 [2] |
| (2r)-4-(2-Benzoyl-1,2-Diazepan-1-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)butan-2-Amine | IC50 | 89120.0 [1], 89125.09 [2] |
| (3Ar,6aS)-5-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N,N,5-trimethyl-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrole-2-carboxamide | IC50 | 4890.0 [1], 38480.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-2-[4-(2,6-dimethoxypyrimidin-4-yl)cyclohexyl]-N,N-dimethyl-4-oxobutanamide | IC50 | 100000.0 [1] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)cyclohexyl]butanamide | IC50 | 22000.0 [1], 100000.0 [2] |
| N-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]-N-methylacetamide | IC50 | 5800.0 [1], 100000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]cyclohexyl]ethanamine | IC50 | 10000.0 [1], 100000.0 [2] |
| 1-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]piperidine-3-carboxamide | IC50 | 14000.0 [1], 68000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-(3,3-difluoropyrrolidin-1-yl)cyclohexyl]ethanamine | IC50 | 22000.0 [1], 100000.0 [2] |
| cis-(R)-2-(2,5-Difluorophenyl)-1-(4-(piperidin-1-yl)cyclohexyl)ethanamine | IC50 | 21000.0 [1], 56000.0 [2] |
| (2S)-2-Amino-4-[(3R)-4-[bis(4-fluorophenyl)methyl]-3-methylpiperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione;2,2,2-trifluoroacetic acid | IC50 | 50.0 [1] |
| (2S)-2-Amino-4-[(3R)-4-[bis(4-fluorophenyl)methyl]-3-methylpiperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione;2,2,2-trifluoroacetic acid | Ki | 37.0 [1] |
| (2S)-2-Amino-4-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione;2,2,2-trifluoroacetic acid | IC50 | 9.9 [1] |
| (2S)-2-Amino-4-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione;2,2,2-trifluoroacetic acid | Ki | 6.5 [1] |
| (R)-3-Amino-1-(2-benzoylpiperazin-1-yl)-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride | IC50 | 100000.0 [1] |
| Sitagliptin phosphate | IC50 | 11000.0 [1] |
| Teneligliptin | IC50 | 260.0 [1] |
| Diprotin A | Ki | 39000.0 [1] |
| Trelagliptin | IC50 | 100000.0 [1] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide;hydrochloride | IC50 | 100000.0 [1] |
| Dutogliptin | IC50 | 8427.0 [1] |
| Gosogliptin | IC50 | 7000.0 [1] |
| (S)-2-Amino-2-cyclohexyl-1-(pyrrolidin-1-YL)ethanone | IC50 | 78.0 [1] |
| Grassystatin A | IC50 | 10000.0 [1] |
| Py(D)AlaboroPro | IC50 | 5600.0 [1] |
| Abt-279 | Ki | 30000.0 [1] |
| Imigliptin | IC50 | 100000.0 [1] |
| 1-Pentanone, 2-amino-3-methyl-1-(1-pyrrolidinyl)-, (2S,3S)- | IC50 | 6600.0 [1] |
| N-[4-((S)-1-Amino-2-oxo-2-thiazolidin-3-yl-ethyl)-cyclohexyl]-4-trifluoromethoxy-benzenesulfonamide | IC50 | 930.0 [1] |
| Lys-Pro-CN | IC50 | 340.0 [1] |
| (S)-Pyrrolidin-1-yl(pyrrolidin-2-yl)methanone | IC50 | 50000.0 [1] |
| Dbpr-108 | IC50 | 100000.0 [1] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide | IC50 | 100000.0 [1] |
| (2-Diphenoxyphosphorylpyrrolidin-1-yl)-[(2S)-pyrrolidin-2-yl]methanone | IC50 | 71000.0 [1] |
| (S)-2,6-Diamino-1-(piperidin-1-yl)hexan-1-one | IC50 | 40500.0 [1] |
| 2-Oxo-2-pyrrolidin-1-ylethanamine | IC50 | 1000000.0 [1] |
| (S)-3-Amino-4-oxo-4-(pyrrolidin-1-yl)butanoic acid | IC50 | 1000000.0 [1] |
| 2-Amino-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione | IC50 | 14.0 [1] |
| (S)-2-Amino-1-(pyrrolidin-1-yl)propan-1-one | IC50 | 411000.0 [1] |
| 6-((3S,5S)-5-(Thiazolidine-3-carbonyl)pyrrolidin-3-ylamino)nicotinonitrile | IC50 | 4756.0 [1] |
| Phe-Pro-CN | IC50 | 210.0 [1] |
| (2R)-2-[4-[[[(2S)-3-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-3-methylbutanoic acid | IC50 | 21000.0 [1] |
| (R)-1-(2-(1-Oxoisoindolin-2-yl)acetyl)pyrrolidin-2-ylboronic acid | IC50 | 11000.0 [1] |
| 4,5,6,7-Tetrachloro-2-[3-(2-phenylethyl)phenyl]isoindole-1,3-dione | IC50 | 21000.0 [1] |
| Sitagliptin Analog 13 | IC50 | 69000.0 [1] |
| (3R)-3-Amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one | IC50 | 46000.0 [1] |